fluorexon has been researched along with Animal Mammary Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoi, A; Horie, S; Kodama, T; Matsumura, Y; Mori, S; Morikawa, H; Tomita, N; Vassaux, G; Watanabe, Y | 1 |
| Chiu, P; Ferrara, KW; Kheirolomoom, A; Kruse, DE; Paoli, EE; Seo, JW; Stahlberg, H; Watson, KD; Zhang, H | 1 |
2 other study(ies) available for fluorexon and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Low-intensity ultrasound and microbubbles enhance the antitumor effect of cisplatin.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Line; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Fluoresceins; Fluorescent Dyes; Genes, Reporter; HT29 Cells; Humans; Kidney; Luciferases, Renilla; Mammary Neoplasms, Animal; Mice; Microbubbles; Particle Size; Transfection; Ultrasonics | 2008 |
An optical and microPET assessment of thermally-sensitive liposome biodistribution in the Met-1 tumor model: Importance of formulation.
Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Cryoelectron Microscopy; Drug Compounding; Female; Fluoresceins; Fluorescent Dyes; Injections, Intravenous; Lipids; Liposomes; Mammary Neoplasms, Animal; Mice; Particle Size; Positron-Emission Tomography; Reproducibility of Results; Spectrometry, Fluorescence; Succinimides; Surface Properties; Technology, Pharmaceutical; Temperature | 2010 |